Revised EU GMP Annex 1 Compliance: Contamination Control Approach

Meeting the new standards and expectations set out in the revised EU GMP Annex 1 regulation is challenging. All manufacturers of sterile medicinal product sold within the EU need to minimize the risk of microbial, particulate and endotoxin/pyrogen contamination.

Achieving EU GMP Annex 1 compliance through an end-to-end approach to contamination control

In this whitepaper, you will learn:

Read time :

3 minutes

Planning a master contamination control framework

Building an effective change management communication strategy

Packaging containment offerings to reduce risks to patient safety

Achieving EU GMP Annex 1 Compliance in Sterile Manufacturing

First Name

Last Name

Company Name

Work Email

Country

Yes, I would like to receive email updates from West.

By providing your contact information and checking this box, you are consenting to the use of your personal data as described in our Privacy Policy, and assenting to the website Terms and Conditions of Use.